Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.
Interius BioTherapeutics is a business in biopharma, biotechnology, health care, therapeutics based in Greater Philadelphia Area, Great Lakes, Northeastern US, founded in 2019.
The company sits in the biopharma, biotechnology, health care, therapeutics segment, where it competes on its core product or service.
The business is associated with Greater Philadelphia Area, Great Lakes, Northeastern US.
The company is listed at the Series_B stage of development.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $154.4M in funding.
| Sector | Biopharma, Biotechnology, Health Care, Therapeutics |
|---|---|
| Headquarters | Greater Philadelphia Area, Great Lakes, Northeastern US |
| Founded | 2019 |
| Employees | c_00011_00050 |
| Stage | series_b |
| Total funding | $154,383,867 |
Website: interiusbio.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account